down arrow

Select Medical Holdings Corp.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US81619Q1058
USD
15.03
-0.04 (-0.27%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

14.9915.18

52 Week

11.6520.83
Valuation
Technical
Day's Volume

CASH

908.43 k

Shareholding (Mar 2025)

FII

7.26%

Held by 120 FIIs

DII

41.81%

Held by 65 DIIs

Promoter

0.01%

How big is Select Medical Holdings Corp.?

22-Jun-2025

As of Jun 18, Select Medical Holdings Corp. has a market capitalization of $1.89 billion, with net sales of $6.19 billion and a net profit of $234 million over the latest four quarters.

As of Jun 18, Select Medical Holdings Corp. has a market capitalization of 1,893.38 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 18, the company reported net sales of 6,186.61 million and a net profit of 234.04 million for the latest four quarters.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 1,681.36 million and total assets of 5,607.95 million.

Read More

What does Select Medical Holdings Corp. do?

22-Jun-2025

Select Medical Holdings Corporation operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the U.S. It reported net sales of $1.35 billion and a net profit of $74 million as of March 2025, with a market cap of approximately $1.89 billion.

Overview:<BR>Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States, categorized within the hospital industry and classified as a small-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1,353 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 74 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 1,893.38 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 8.00 <BR>Dividend Yield: 2.52% <BR>Debt Equity: 1.13 <BR>Return on Equity: 15.17% <BR>Price to Book: 1.10 <BR><BR>Contact Details:<BR>Address: 4714 Gettysburg Rd, MECHANICSBURG PA: 17055-4325 <BR>Tel: 1 717 9721100 <BR>Website: http://www.selectmedical.com/

Read More

Who are in the management team of Select Medical Holdings Corp.?

22-Jun-2025

As of March 2022, the management team of Select Medical Holdings Corp. includes Executive Chairman Robert Ortenzio, Vice Chairman Rocco Ortenzio, and several independent directors with extensive experience, such as Russell Carson and Thomas Scully.

As of March 2022, the management team of Select Medical Holdings Corp. includes:<BR><BR>- Mr. Robert Ortenzio, Executive Chairman of the Board and Co-Founder<BR>- Mr. Rocco Ortenzio, Vice Chairman of the Board and Co-Founder<BR>- Mr. Russell Carson, Lead Independent Director<BR>- Mr. Bryan Cressey, Independent Director<BR>- Mr. James Ely, Independent Director<BR>- Dr. William Frist, Independent Director<BR>- Mr. Thomas Scully, Independent Director<BR><BR>This team comprises individuals with significant experience and leadership roles within the company.

Read More

Is Select Medical Holdings Corp. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Select Medical Holdings Corp. has a mildly bearish trend, with mixed technical indicators and a year-to-date return of -30.98%, significantly underperforming the S&P 500's 14.18%.

As of 3 October 2025, the technical trend for Select Medical Holdings Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD is mildly bullish on a weekly basis but bearish monthly, while the RSI shows no signal for both time frames. Bollinger Bands and moving averages are both mildly bearish on a daily and weekly basis. The KST is bearish across both weekly and monthly periods, but the Dow Theory indicates a mildly bullish weekly stance. OBV is mildly bullish on both weekly and monthly charts.<BR><BR>In terms of performance, Select Medical has underperformed the S&P 500 across multiple periods, with a year-to-date return of -30.98% compared to the S&P 500's 14.18%, and a one-year return of -28.23% versus 17.82% for the index.

Read More

Is Select Medical Holdings Corp. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Select Medical Holdings Corp. is considered overvalued with a P/E ratio of 8 and a year-to-date return of -28.97%, underperforming the S&P 500's 13.30%.

As of 17 October 2025, the valuation grade for Select Medical Holdings Corp. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 8, an EV to EBITDA ratio of 6.47, and a Price to Book Value of 1.15. In comparison, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while Chemed Corp. shows a significantly higher P/E of 56.91, reflecting a stark contrast in valuation among peers.<BR><BR>The recent stock performance shows Select Medical Holdings Corp. underperforming relative to the S&P 500, with a year-to-date return of -28.97% compared to the S&P 500's 13.30%. This underperformance, combined with the current valuation metrics, reinforces the conclusion that the stock is overvalued in the current market environment.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate -3.46% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Capital Employed (avg) of 10.76% signifying low profitability per unit of total capital (equity and debt)
2

Negative results in Jun 25

3

With ROCE of 11.80%, it has a very expensive valuation with a 1.07 Enterprise value to Capital Employed

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 1,643 Million (Small Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.42%

stock-summary
Debt Equity

1.20

stock-summary
Return on Equity

13.57%

stock-summary
Price to Book

0.99

Revenue and Profits:
Net Sales:
1,340 Million
(Quarterly Results - Jun 2025)
Net Profit:
57 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.53%
0%
15.53%
6 Months
-1.38%
0%
-1.38%
1 Year
-26.75%
0%
-26.75%
2 Years
16.92%
0%
16.92%
3 Years
12.08%
0%
12.08%
4 Years
-1.28%
0%
-1.28%
5 Years
11.95%
0%
11.95%

Select Medical Holdings Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Select Medical Holdings Corp. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Select Medical Holdings Corp. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 8, an EV to EBITDA ratio of 6.47, and a Price to Book Value of 1.15. In comparison, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while Chemed Corp. shows a significantly higher P/E of 56.91, reflecting a stark contrast in valuation among peers. The recent stock performance shows Select Medical Holdings Corp. underperforming relative to the S&P 500, with a year-to-date return of -28.97% compared to the S&P 500's 13.30%. This underperformance, combined with the current valuation metrics, reinforces the conclusion that the stock is overvalued in the current market environment....

Read More

Is Select Medical Holdings Corp. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Select Medical Holdings Corp. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 8, an EV to EBITDA ratio of 6.47, and a Price to Book Value of 1.15. In comparison to peers, Universal Health Services, Inc. has a higher P/E of 9.20, while Surgery Partners, Inc. has an EV to EBITDA of 8.44, suggesting that Select Medical is trading at a lower valuation relative to some competitors despite its high valuation grade. Additionally, Select Medical's recent stock performance has been underwhelming, with a year-to-date return of -28.97% compared to the S&P 500's 13.30%, and a one-year return of -27.49% versus the S&P 500's 14.08%. This underperformance reinforces the notion that the stock may be overvalued in the current market context....

Read More

Is Select Medical Holdings Corp. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Select Medical Holdings Corp. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued, particularly with a P/E ratio of 8, which is below the peer average of 9.21 for Universal Health Services, Inc. and significantly lower than Chemed Corp.'s P/E of 56.91. Additionally, the EV to EBITDA ratio stands at 6.47, which is more favorable compared to Surgery Partners, Inc. at 8.44, but still suggests a premium valuation relative to its peers. Despite a dividend yield of 2.40% and a solid ROE of 15.17%, the company's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -28.97% compared to the index's 13.30%. This underperformance, combined with the high valuation ratios, reinforces the conclusion that Select Medical Holdings Corp. is currently overvalued....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.26%
EBIT Growth (5y)
-3.46%
EBIT to Interest (avg)
3.04
Debt to EBITDA (avg)
4.83
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
1.39
Tax Ratio
24.05%
Dividend Payout Ratio
30.18%
Pledged Shares
0
Institutional Holding
90.43%
ROCE (avg)
10.76%
ROE (avg)
22.36%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.15
EV to EBIT
9.09
EV to EBITDA
6.47
EV to Capital Employed
1.07
EV to Sales
0.64
PEG Ratio
NA
Dividend Yield
2.40%
ROCE (Latest)
11.80%
ROE (Latest)
15.17%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 82 Schemes (50.84%)

Foreign Institutions

Held by 120 Foreign Institutions (7.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -1.01% vs 3.09% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -22.42% vs 843.43% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,339.60",
          "val2": "1,353.20",
          "chgp": "-1.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "119.80",
          "val2": "147.60",
          "chgp": "-18.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "30.00",
          "val2": "29.10",
          "chgp": "3.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "57.10",
          "val2": "73.60",
          "chgp": "-22.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "63.40%",
          "val2": "83.30%",
          "chgp": "-1.99%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.48% vs -23.80% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.91% vs -43.71% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,187.10",
          "val2": "4,826.00",
          "chgp": "7.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "407.80",
          "val2": "401.40",
          "chgp": "1.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "192.60",
          "val2": "234.90",
          "chgp": "-18.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-25.40",
          "val2": "-13.20",
          "chgp": "-92.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "127.70",
          "val2": "108.30",
          "chgp": "17.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.10%",
          "val2": "55.10%",
          "chgp": "-0.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
1,339.60
1,353.20
-1.01%
Operating Profit (PBDIT) excl Other Income
119.80
147.60
-18.83%
Interest
30.00
29.10
3.09%
Exceptional Items
0.00
0.00
Consolidate Net Profit
57.10
73.60
-22.42%
Operating Profit Margin (Excl OI)
63.40%
83.30%
-1.99%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -1.01% vs 3.09% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -22.42% vs 843.43% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5,187.10
4,826.00
7.48%
Operating Profit (PBDIT) excl Other Income
407.80
401.40
1.59%
Interest
192.60
234.90
-18.01%
Exceptional Items
-25.40
-13.20
-92.42%
Consolidate Net Profit
127.70
108.30
17.91%
Operating Profit Margin (Excl OI)
51.10%
55.10%
-0.40%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 7.48% vs -23.80% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 17.91% vs -43.71% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Select Medical Holdings Corp. stock-summary
stock-summary
Select Medical Holdings Corp.
Hospital
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company's segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. As of December 31, 2016, the Company had operations in 46 states and the District of Columbia.
Company Coordinates stock-summary
Company Details
4714 Gettysburg Rd , MECHANICSBURG PA : 17055-4325
stock-summary
Tel: 1 717 9721100
stock-summary
http://www.selectmedical.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."